Alvotech Files June 2025 6-K Report
Ticker: ALVOW · Form: 6-K · Filed: Jun 25, 2025 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, regulatory-update
TL;DR
Alvotech filed its June 6-K, confirming 20-F annual report filings.
AI Summary
Alvotech, a biopharmaceutical company, filed a Form 6-K on June 25, 2025. This report is for the month of June 2025 and indicates that Alvotech files its annual reports under Form 20-F. The company's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg.
Why It Matters
This filing provides routine updates and confirms Alvotech's reporting status with the SEC, which is important for investors tracking the company's compliance and disclosures.
Risk Assessment
Risk Level: low — This is a routine filing that does not contain new material financial information or significant operational updates.
Key Players & Entities
- Alvotech (company) — Filer of the 6-K report
- 001-41421 (company) — SEC File Number for Alvotech
- 9, Rue de Bitbourg, L-1273 Luxembourg (company) — Principal executive office address
- 20250625 (date) — Filing date of the report
FAQ
What type of report is Alvotech filing?
Alvotech is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is June 25, 2025.
Does Alvotech file annual reports under Form 20-F or 40-F?
Alvotech indicates that it files annual reports under cover of Form 20-F.
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg.
What is the SEC file number for Alvotech?
Alvotech's SEC file number is 001-41421.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 25, 2025 regarding Alvotech (ALVOW).